Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pacific Bridge NY (PBNY) is a venture fund dedicated to enhancing cross-border biotech value, particularly between Asia and Western markets. Founded with a focus on advancing global intellectual property, the firm employs cost-effective clinical development strategies. PBNY operates globally, with a strong emphasis on North America and Asia.
PBNY invests in biotech companies that exhibit strong biological rationale and clear paths to regulatory approval in Western markets. The fund emphasizes sourcing cross-border opportunities and leveraging clinical expertise to support drug development. Investment stages range from pre-seed to growth equity, with a focus on flexible company-building structures.
Submit through their form at pacificbridgeny.com or email info@pacificbridgeny.com with your deck.
Yes, Pacific Bridge NY often leads investment rounds, particularly in early-stage biotech companies that align with their focus on cross-border opportunities.
The firm is open to follow-on investments, especially in companies that demonstrate significant progress and potential for further development in Western markets.
Specific details about the fund size are not publicly available, but PBNY is known for making substantial investments in promising biotech ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.